These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26966488)

  • 1. Multiple myeloma in Nigeria: a multi-centre epidemiological and biomedical study.
    Nnonyelum ON; Anazoeze MJ; Eunice NO; Emmanuel OO; Stella AT; Marcus AI; Taiwo BM; Olufela KO; Chinawaeze AJ; Orkuma JA; Dalhat GG; Otobo UI
    Pan Afr Med J; 2015; 22():292. PubMed ID: 26966488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma in Nigeria: an insight to the clinical, laboratory features, and outcomes.
    Madu AJ; Ocheni S; Nwagha TA; Ibegbulam OG; Anike US
    Niger J Clin Pract; 2014; 17(2):212-7. PubMed ID: 24553034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelomatosis: clinical and laboratory features in Nigerians.
    Salawu L; Durosinmi MA
    West Afr J Med; 2005; 24(1):54-7. PubMed ID: 15909712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Involvement as a Presenting Feature of Multiple Myeloma.
    Salahuddin AZ; Alam MR; Hossain RM; Feroz S; Zannat H; Mondal MC; Roy AS; Robbani MG; Uddin MB; Kadir MS
    Mymensingh Med J; 2019 Jul; 28(3):527-535. PubMed ID: 31391422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
    Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
    Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and laboratory features of plasma cell neoplasialn the University of Port Harcourt Teaching Hospital.
    Omunakwe HE; Korubo KI; Onodingene N; Nwauche CA
    Niger J Med; 2013; 22(3):225-9. PubMed ID: 24180152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma--presenting as acute kidney injury.
    Prakash J; Niwas SS; Parekh A; Vohra R; Wani IA; Sharma N; Usha
    J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.
    Bashir Q; Thall PF; Milton DR; Fox PS; Kawedia JD; Kebriaei P; Shah N; Patel K; Andersson BS; Nieto YL; Valdez BC; Parmar S; Rondon G; Delgado R; Hosing C; Popat UR; Oran B; Ciurea SO; Lin P; Weber DM; Thomas SK; Lee HC; Manasanch EE; Orlowski RZ; Williams LA; Champlin RE; Qazilbash MH
    Lancet Haematol; 2019 May; 6(5):e266-e275. PubMed ID: 30910541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in multiple myeloma in Kerala.
    Nair MK; Varghese C; Krishnan E; Sankaranarayanan R; Nair B
    Natl Med J India; 1993; 6(1):7-10. PubMed ID: 8453369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
    Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
    Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUSCULOSKELETAL PRESENTATION OF MULTIPLE MYELOMA AT GENERAL HOSPITAL DOUALA, CAMEROON.
    Doualla-Bija M; Ndongho EN; Oben DT; Namme HL; Mbanya D
    East Afr Med J; 2014 Sep; 91(9):311-6. PubMed ID: 26866083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases.
    Acquah ME; Hsing AW; McGuire V; Wang S; Birmann B; Dei-Adomakoh Y
    Ghana Med J; 2019 Mar; 53(1):52-58. PubMed ID: 31138944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over.
    Sirohi B; Powles R; Treleaven J; Mainwaring P; Kulkarni S; Pandha H; Bhagwati N; Horton C; Singhal S; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):533-9. PubMed ID: 10713631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma: uncommon or uncommonly diagnosed?
    Newton PA
    Postgrad Med; 1977 May; 61(5):107-10. PubMed ID: 857246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell transplantation for multiple myeloma: Long-term results.
    Kumar L; Boya RR; Pai R; Harish P; Mookerjee A; Sainath B; Patekar MB; Sahoo RK; Malik PS; Sharma OD; Gupta R
    Natl Med J India; 2016; 29(4):192-199. PubMed ID: 28050994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant.
    Chang H; Samiee S; Yi QL
    Leuk Lymphoma; 2006 Jan; 47(1):43-7. PubMed ID: 16321826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.